• Erker L, Wynshaw-Boris A, Warshawsky D, and Landolph J (2005) Molecular Carcinogenesis; Oncogenesis in Transgenic and Knockout Mice.  CRC Press LLC (in press).

• Erker L, Schubert R, Yakushiji H, Barlow C, Larson D, Mitchell JB, and Wynshaw-Boris A (2005) Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor.  Hum Mol Genet. (in press). Abstract

• Webster NJ, Evans LG, Caples M, Erker L, Chew SL (2004)   Assembly of splicing complexes on exon 11 of the human insulin receptor gene does not correlate with splicing efficiency in-vitro.  BMC Mol Biol. 5(1):7.  Abstract

• Erker L, Schubert R, Barlow C, Yakushiji H, Larson D, Russo A , Mitchell JB and Wynshaw-Boris A (2004)  Cancer chemoprevention by the antioxidant Tempol in cancer prone mice.  Hum Mol Genet. 13(16):1793-802.  Abstract

• Eichhorn J, Kayali AG, Resor* L, Austin DA, Rose D, and Webster NJ (2002)  PLC-gamma-1 enzyme activity is required for insulin-induced DNA synthesis. Endocrinology 143(2):655-64. Abstract
  
• Resor* L, Bowen TJ, and Wynshaw-Boris A (2001) Unraveling human cancer in the mouse: recent refinements to modeling and analysis. Hum Mol Genet. (7):669-75. Review.  Abstract